These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7631546)

  • 1. Diagnostic value of p53 protein in the study of serous effusions.
    Zoppi JA; Pellicer EM; Sundblad AS
    Acta Cytol; 1995; 39(4):721-4. PubMed ID: 7631546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oncologic diagnosis of serous effusions in body cavities (cytologic study and evaluation of cholesterol and carcinoembryonic antigen levels)].
    Gulyás M; Elek G; Molnár M; Szollár L
    Orv Hetil; 1995 Nov; 136(45):2453-8. PubMed ID: 8524550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology.
    Ko EC; Jhala NC; Shultz JJ; Chhieng DC
    Am J Clin Pathol; 2001 Nov; 116(5):709-15. PubMed ID: 11710688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin.
    Athanassiadou P; Athanassiades P; Lazaris D; Kyrkou K; Petrakakou E; Aravantinos D
    Acta Cytol; 1994; 38(5):718-22. PubMed ID: 8091904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of AgNOR technique in the interpretation of serous effusions].
    Rocher AE; Blanco AM; Palaoro LA
    Rev Med Chil; 2000 Sep; 128(9):963-8. PubMed ID: 11349500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV; Nesland JM; Davidson B
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of thrombomodulin immunolocalization in serous effusions.
    Ascoli V; Scalzo CC; Taccogna S; Nardi F
    Arch Pathol Lab Med; 1995 Dec; 119(12):1136-40. PubMed ID: 7503662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.
    Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H
    Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is immunoreactivity for p53 useful in distinguishing benign from malignant effusions? Localization of p53 gene product in benign mesothelial and adenocarcinoma cells.
    Walts AE; Said JW; Koeffler HP
    Mod Pathol; 1994 May; 7(4):462-8. PubMed ID: 8066074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH; Kim GE; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Ki67 immunostain in identification of malignancy in serous effusions.
    Saleh H; Bober P; Tabaczka P
    Diagn Cytopathol; 1999 Jan; 20(1):24-8. PubMed ID: 9884823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis between exudate and transudate in pleural effusion].
    Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B
    Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase activity in various pathological effusions.
    Makhlouf NA; Nassar G; Makhlouf M; Habbal Z
    J Med Liban; 1992; 40(3):142-4. PubMed ID: 1339893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
    Loy TS; Diaz-Arias AA; Bickel JT
    Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of cholesterol in pleural effusions.
    Ram KN; Sing RS
    J Assoc Physicians India; 1995 Nov; 43(11):748-50. PubMed ID: 8773031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell adhesion molecule, E-cadherin, distinguishes mesothelial cells from carcinoma cells in fluids.
    Schofield K; D'Aquila T; Rimm DL
    Cancer; 1997 Oct; 81(5):293-8. PubMed ID: 9349517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.